hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.
about
Advances in the treatment of erectile dysfunction: what's new and upcoming?The treatment of erectile dysfunction in patients with neurogenic diseaseFunction and regulation of large conductance Ca(2+)-activated K+ channel in vascular smooth muscle cellsIntracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?Drugs in preclinical to phase II clinical development for the treatment of erectile dysfunction.Research in pharmacotherapy for erectile dysfunctionOpiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.Future prospects in the treatment of erectile dysfunction: focus on avanafil.Current Diagnosis and Management of Erectile DysfunctionReversal of diabetic vasculopathy in a rat model of type 1 diabetes by opiorphin-related peptidesOptimizing postoperative sexual function after radical prostatectomyGenetic activation of BK currents in vivo generates bidirectional effects on neuronal excitability.Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.Testosterone regulates erectile function and Vcsa1 expression in the corpora of rats.Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?Emerging gene and stem cell therapies for the treatment of erectile dysfunction.Gene therapy as future treatment of erectile dysfunctionEmerging and novel therapeutic approaches in the treatment of male erectile dysfunction.Emerging tools for erectile dysfunction: a role for regenerative medicine.Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches.Treatment strategies for diabetic patients suffering from erectile dysfunction: an update.Emerging drugs for the treatment of erectile dysfunction.Neuroprotective and Nerve Regenerative Approaches for Treatment of Erectile Dysfunction after Cavernous Nerve Injury.Development and therapeutic applications of nitric oxide releasing materials to treat erectile dysfunction.Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact.Silencing MaxiK activity in corporal smooth muscle cells initiates compensatory mechanisms to maintain calcium homeostasis.Ageing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells.Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.Effects of Next-Generation Low-Energy Extracorporeal Shockwave Therapy on Erectile Dysfunction in an Animal Model of Diabetes.Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model.A synthetic erectile optogenetic stimulator enabling blue-light-inducible penile erection.
P2860
Q26741767-9D39CCC4-5048-4778-83FE-FA68D218E3D9Q26767305-5956B662-C7E9-43A9-BF99-8E5F318BACFDQ26995779-5C6DB3D0-4486-45A1-B72B-22343F87B92BQ27025843-493D72C6-39C5-4648-979D-50D63E2B57A3Q30252468-4CB3A812-9C9E-441E-B6BC-0581F2AC25CEQ33650796-6141C3DE-2832-4D19-8453-C593B2ADB702Q33913200-40DFE281-FF79-4DFD-B7F8-94688648AB20Q34029414-C85C4CB8-C1D4-4EA8-9FBB-9517E6D4344BQ35384480-739C5359-BE4E-48A5-AE92-82E763E44EB7Q35395573-718A5302-CDB6-48F8-AB2F-DF26C5EB2286Q36379338-B235D599-1EE4-4326-8851-B8CE07E467FEQ36414675-569E8FD1-156F-43AE-940A-69214841AC6CQ36815916-92286CA3-7677-4980-BC9B-3D659D44D365Q37222126-B934F3D9-FC1C-4BFB-A178-588EE5A73087Q37230725-10E4CB99-ECF0-4B9A-8C5D-130F7DE6EE11Q37692808-E8D2E3D3-78DC-4EAC-B623-BA799B57FAB6Q37775988-5FA90E2C-6E24-48EB-A0FD-9160518CF928Q37933090-6D45E3C4-67EB-4362-B46D-0DD9FEE2939FQ38028739-037C60A6-3F58-4624-BF3B-F2333EB6AD3AQ38105311-8A363217-E8FE-4457-B0AA-E64F5C913E52Q38224353-7EAE7DFA-BD36-46E1-A517-A80654D8CEABQ38367700-17D3DF10-4152-4263-841F-F12B73BB4724Q38640386-6EFCE3DF-74BA-4B6F-BA48-636A312E2BD9Q38889467-F60FA889-97C5-4D09-926D-3C795DA2C797Q38966016-CCC8C901-2FCB-4ABD-8084-88C81719892EQ42002134-1F39EDC7-8268-4590-9724-2B6E927B7A64Q42628321-C04707A1-1529-4DCD-B041-DFB6190CD3CEQ45874502-955E30A5-DFA1-42D8-BF9A-99BABEB43B58Q45874863-95323E50-92F1-4292-89C4-07749D9D9B58Q45875110-625FE261-8DE7-4313-BFB0-2D3D9B032DCEQ50216367-66C8963C-F2AE-4DCE-B4AA-E63AB65B994C
P2860
hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
hMaxi-K gene transfer in males ...... ults of the first human trial.
@en
hMaxi-K gene transfer in males ...... ults of the first human trial.
@nl
type
label
hMaxi-K gene transfer in males ...... ults of the first human trial.
@en
hMaxi-K gene transfer in males ...... ults of the first human trial.
@nl
prefLabel
hMaxi-K gene transfer in males ...... ults of the first human trial.
@en
hMaxi-K gene transfer in males ...... ults of the first human trial.
@nl
P2093
P356
P1433
P1476
hMaxi-K gene transfer in males ...... sults of the first human trial
@en
P2093
Andrew McCullough
Arnold Melman
George Christ
Natan Bar-Chama
P304
P356
10.1089/HUM.2006.17.1165
P577
2006-12-01T00:00:00Z